Clinical Trial Update: Randomized Trial on Effectiveness of ACTs in Ghana [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating artemisinin-based combination therapies for falciparum malaria in Ghana has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Artemisinin-based combination therapy (ACT)

Snippet

Sponsor: Bernhard Nocht Institute for Tropical Medicine | Conditions: Malaria, Falciparum | Phase 4 | Status: TERMINATED